Abstract
The heart and the kidneys are linked and work in concert to manage blood pressure, salt and water balance, neurohormonal systems, and cell signaling systems. The presence of chronic kidney disease has consistently predicted the development and worsening of cardiovascular disease in human studies. The most prominent feature of atherosclerosis in patients with kidney disease is accelerated calcification as a manifestation of mineral and bone disorder. The development of effort intolerance, dyspnea, and peripheral edema commonly heralds the presence of heart failure but can also be attributed to some forms of chronic kidney disease, particularly nephrotic syndrome. Hospitalization for heart failure is the most frequent manifestation of cardiovascular disease in patients with kidney disease. The most common forms of valvular disease are aortic valve calcification resulting in sclerosis and/or stenosis and/or mitral annular calcification. Because of myocardial disease, electrolyte imbalance, and acid-base disturbances, all forms of arrhythmias are more frequent in patients with kidney disease, particularly those patients receiving dialysis therapy. In summary, there is a very strong link between heart and kidney disease, and hence, they can be viewed as a “cardiorenal” system at risk for disease in both organs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2010;165:54–67.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17–28.
McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Kidney Early Evaluation Program Investigators, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2008;51(4 Suppl 2):S38–45.
McCullough PA, Chinnaiyan KM, Agrawal V, Danielewicz E, Abela GS. Amplification of atherosclerotic calcification and Mönckeberg’s sclerosis: a spectrum of the same disease process. Adv Chronic Kidney Dis. 2008;15(4):396–412.
McCullough PA, Agarwal M, Agrawal V. Review article: risks of coronary artery calcification in chronic kidney disease: do the same rules apply? Nephrology (Carlton). 2009;14(4):428–36.
Charytan DM, Kuntz RE, Garshick M, Candia S, Khan MF, Mauri L. Location of acute coronary artery thrombosis in patients with and without chronic kidney disease. Kidney Int. 2009;75(1):80–7.
Lubanski MS, McCullough PA. Kidney’s role in hypertension. Minerva Cardioangiol. 2009;57(6):743–59.
McCullough PA, Olobatoke A, Vanhecke TE. Galectin-3: a novel blood test for the evaluation and management of patients with heart failure. Rev Cardiovasc Med. 2011;12(4):200–10.
Hanson ID, McCullough PA. B-type natriuretic peptide: beyond diagnostic applications. In: Bakris GL, editor. The kidney in heart failure. New York: Springer; 2012. p. 67–77.
Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012;60:1031–42.
Maraj S, Jacobs LE, Maraj R, Kotler MN. Bacteremia and infective endocarditis in patients on hemodialysis. Am J Med Sci. 2004;327:242–9.
Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28(19):2307–12.
Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 2008;21(4):300–7.
McCullough PA, Wase A. Do implantable cardioverter-defibrillators improve survival in dialysis patients after cardiac arrest? Nat Clin Pract Nephrol. 2006;2(2):70–1.
Dager WE, Kiser TH. Systemic anticoagulation considerations in chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(5):420–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McCullough, P.A., Nasser, M. (2014). Chronic Kidney Disease and the Cardiovascular Connection. In: Arici, M. (eds) Management of Chronic Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54637-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-54637-2_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54636-5
Online ISBN: 978-3-642-54637-2
eBook Packages: MedicineMedicine (R0)